(RS)-MCPG 50 mg | Purity Not Available
TargetMol
(RS)-MCPG is a non-selective group I/II metabotropic glutamate receptor antagonist.
More Information Supplier Page(RS)-MCPG
Search Results
NU2058 5 mg | 99.95%
TargetMol
NU2058 is a guanine-based CDK inhibitor, also inhibits DNA topoisomerase II ATPase activity.
More Information Supplier PageNU2058
NU2058 50 mg | 99.95%
TargetMol
NU2058 is a guanine-based CDK inhibitor, also inhibits DNA topoisomerase II ATPase activity.
More Information Supplier PageNU2058
NU2058 25 mg | 99.95%
TargetMol
NU2058 is a guanine-based CDK inhibitor, also inhibits DNA topoisomerase II ATPase activity.
More Information Supplier PageNU2058
NU2058 10 mg | 99.95%
TargetMol
NU2058 is a guanine-based CDK inhibitor, also inhibits DNA topoisomerase II ATPase activity.
More Information Supplier PageNU2058
NU2058 100 mg | 99.95%
TargetMol
NU2058 is a guanine-based CDK inhibitor, also inhibits DNA topoisomerase II ATPase activity.
More Information Supplier PageNU2058
Metadoxine 100 mg | Purity Not Available
TargetMol
Metadoxine
Metadoxine 50 mg | Purity Not Available
TargetMol
Metadoxine
Tulobuterol hydrochloride 100 mg | Purity Not Available
TargetMol
Tulobuterol hydrochloride is a long-acting beta2-adrenergic receptor agonist.
More Information Supplier PageTulobuterol hydrochloride
Tulobuterol hydrochloride 50 mg | Purity Not Available
TargetMol
Tulobuterol hydrochloride is a long-acting beta2-adrenergic receptor agonist.
More Information Supplier PageTulobuterol hydrochloride